Delayed SEC reports
Compare what managers reported this quarter with last quarter. These reports are delayed.Large US investment managers report many holdings every quarter. We compare the shares they reported this quarter with the prior quarter. The reports arrive late and do not show the exact trade day, trade price, shorts, cash, or the manager’s reason.
14 of 16 managers have a matching row in their newest complete report.
$875.10 B total reported value across 13575 holdings · 13F-HR · filed Aug 14, 2026 · open SEC report ↗
How to read this manager
Citadel often reports shares, calls, and puts at the same time. These rows show reported exposure, not a simple bullish or bearish bet.
TickerYou therefore keeps this manager out of the group direction ranking, while preserving its common-share and option rows here for investigation.
These managers' newest complete report is at least 2 quarters behind the newest period above. They remain available for history, but are kept separate from managers with newer reports.
For the matching rows, compared with Q1 2026, the Q2 2026 report's stock rows show 115 new positions, 156 positions with more shares reported, 168 positions with fewer shares reported, and 82 positions that no longer appear.
Green + ▲ means new or more shares; red + ▼ means fewer shares or no longer listed. The words and dot count repeat the meaning without relying on colour. Fewer shares or no listing does not mean the manager opened a short position.
Kept outside those common-share counts: 527 option-contract rows, 5 principal-amount positions.
13F reports can arrive up to 45 days after quarter-end, so this comparison is not proof of when, why, or at what price the manager traded.
Green means the manager reported a new or larger share amount. Red means a smaller amount or the stock was no longer listed. This compares two delayed reports; it does not show the exact trade.
Biggest reported changes — ranked by position value. The bar is the position's size against the largest one shown; the figure under it is the difference in the filed SH or principal amount. Corporate actions are not normalized.
Absent from latest filing — a 13F reports only that the position is absent, not when, why, or for what proceeds it changed. The prior SH or principal amount is printed, but these rows are not ranked because those units are not comparable.
PUT and CALL are contract labels, not common-share holdings. A 13F reports these option rows but does not establish whether the strategy is bullish, bearish, hedged, or part of a spread. It also does not reveal strike, expiry, premium, or the rest of the manager's book.
517 more option comparison rows in this filing.
These rows use PRN amounts, not share counts, and are excluded from common-share comparisons.
| Position | Value | Filed amount | Change |
|---|---|---|---|
SEC issuerCREDIT ACCEP CORP MICH | $11.6 M0.0% of filing | 18,256 sh | MORE SHARES |
| $11.2 M0.0% of filing | 300,438 sh | FEWER SHARES | |
SEC issuerARCELORMITTAL SA LUXEMBOURG | $11.2 M0.0% of filing | 185,497 sh | FEWER SHARES |
| $11.1 M0.0% of filing | 2,298,403 sh | MORE SHARES | |
SEC issuerMAGNUM ICE CREAM CO NV | $10.9 M0.0% of filing | 625,139 sh | MORE SHARES |
| $10.8 M0.0% of filing | 1,154,623 sh | MORE SHARES | |
| $9.5 M0.0% of filing | 109,105 sh | FEWER SHARES | |
SEC issuerHARMONY BIOSCIENCES HLDGS IN | $9.3 M0.0% of filing | 255,810 sh | FEWER SHARES |
SEC issuerBETTER HOME & FINANCE HOLDIN | $9.2 M0.0% of filing | 335,989 sh | MORE SHARES |
SEC issuerTENCENT MUSIC ENTMT GROUP | $9.1 M0.0% of filing | 1,084,848 sh | FEWER SHARES |
| $8.9 M0.0% of filing | 278,307 sh | MORE SHARES | |
| $8.8 M0.0% of filing | 52,524 sh | FEWER SHARES | |
| $8.8 M0.0% of filing | 46,239 sh | MORE SHARES | |
| $8.8 M0.0% of filing | 2,104,990 sh | FEWER SHARES | |
| $8.6 M0.0% of filing | 506,668 sh | MORE SHARES | |
| $8.5 M0.0% of filing | 205,406 sh | NEW THIS QUARTER | |
| $8.0 M0.0% of filing | 641,828 sh | FEWER SHARES | |
| $8.0 M0.0% of filing | 96,082 sh | FEWER SHARES | |
| $7.6 M0.0% of filing | 517,144 sh | FEWER SHARES | |
| $7.2 M0.0% of filing | 1,093,243 sh | FEWER SHARES | |
SEC issuerULTRAGENYX PHARMACEUTICAL IN | $7.0 M0.0% of filing | 210,531 sh | FEWER SHARES |
| $7.0 M0.0% of filing | 215,969 sh | FEWER SHARES | |
| $6.5 M0.0% of filing | 79,643 sh | MORE SHARES | |
| $6.3 M0.0% of filing | 265,353 sh | MORE SHARES | |
| $6.1 M0.0% of filing | 157,524 sh | FEWER SHARES |